| abstract |
Disclosed are methods and compositions for improved drug delivery, particularly for antibody-based therapeutics in the treatment or prevention of pulmonary disease. The present invention relates to methods and compositions that use antibodies that inhibit complement system activation and that can be used to prevent or treat lung diseases or conditions. The lung diseases or conditions treated by the present invention include asthma, bronchoconstriction, bronchitis, chronic obstructive pulmonary disease (COPD), interstitial lung disease, lung malignant disease, α-1 antitrypsin deficiency, qi Tumors, bronchiectasis, obstructive bronchiolitis, sarcoidosis, pulmonary fibrosis, and collagen angiopathy include, but are not limited to. [Selection] Figure 1 |